Research map: Engineered exosomes improve myocardial cell membrane integrity and heart function in dystrophic cardiomyopathy
Back to the article
Papers in this map
The biology , function , and biomedical applications of exosomes
· Raghu K. Kalluri · 2020 · 10967 citations · Cited by this paper
Remodelling the tumour microenvironment and beyond: ERO1A as a multifaceted regulator and emerging therapeutic target in cancer
· 2026 · Related
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
· Catherine L. Bladen · 2015 · 762 citations · Cited by this paper
Role of LncSNHG5 in MAFLD: Mechanisms of Arid1a K391 lactylation and lipid accumulation
· 2026 · Related
Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials
· Ahmed Mohamed Lotfy · 2023 · 475 citations · Cited by this paper
Sintilimab plus cisplatin and nab‐paclitaxel induction treatment for locally advanced borderline‐resectable oesophageal squamous cell carcinoma: A single‐arm, prospective, phase 2 study (NEOCRTEC2001)
· 2026 · Related
Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide
· Adam C. Vandergriff · 2018 · 412 citations · Cited by this paper
Integrating pathological morphologies and molecular profiles for clinical biomarker discovery with unified multimodal embedding
· 2026 · Related
Dystrophin-Deficient Cardiomyopathy
· Forum D. Kamdar · 2016 · 395 citations · Cited by this paper
Artificial intelligence and oral microbiome: Reshaping the diagnostic and therapeutic paradigm of OSCC
· 2026 · Related
Therapeutic developments for Duchenne muscular dystrophy
· Ingrid E.C. Verhaart · 2019 · 395 citations · Cited by this paper
Investigations into the aetiopathogenesis of orofacial granulomatosis using multiple omics technologies reveal a potential role for B cells
· 2026 · Related
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment
· Kristen J Nowak · 2004 · 366 citations · Cited by this paper
Releasing the neuronal brake: Inhibiting AhR to enhance axon regeneration
· 2026 · Related
Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis
· Erik Landfeldt · 2020 · 303 citations · Cited by this paper
The emerging dialogue between synthetic genomics and clinical research
· 2026 · Related
Effect of genetic background on the dystrophic phenotype in mdx mice
· William Coley · 2015 · 264 citations · Cited by this paper
Ubc9‐mediated SUMOylation of Ninj1 alleviates inflammatory responses in hepatic ischaemia/reperfusion injury
· 2026 · Related
Extracellular vesicles: The next generation in gene therapy delivery
· Riccardo Cecchin · 2023 · 201 citations · Cited by this paper
Proteomic profiling reveals ACTN1‐mediated cytoskeletal remodelling and hyperplasia of cerebrovascular smooth muscle cells in moyamoya disease
· 2026 · Related
Identification of targeting peptides for ischemic myocardium by in vivo phage display
· Sachiko Kanki · 2011 · 177 citations · Cited by this paper
Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles
· Eleni Tseliou · 2015 · 155 citations · Cited by this paper
Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review
· Zhen Chen · 2024 · 147 citations · Cited by this paper
Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy
· Ariel Bier · 2018 · 143 citations · Cited by this paper
Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy
· Mark A. Aminzadeh · 2018 · 142 citations · Cited by this paper
Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double‐knockout mice
· Maaike van Putten · 2013 · 118 citations · Cited by this paper
Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy
· Courtney S. Young · 2017 · 102 citations · Cited by this paper
Effects of exosome-mediated delivery of myostatin propeptide on functional recovery of mdx mice
· Ning Ran · 2020 · 101 citations · Cited by this paper
Mesenchymal stem cell-derived exosomes in cardiovascular and cerebrovascular diseases: From mechanisms to therapy
· Yanhong Pan · 2023 · 90 citations · Cited by this paper
Engineering exosomes and exosome-like nanovesicles for improving tissue targeting and retention
· Lanya Li · 2024 · 79 citations · Cited by this paper
Targeted Gene Delivery to Ischemic Myocardium by Homing Peptide-Guided Polymeric Carrier
· Young-Wook Won · 2012 · 66 citations · Cited by this paper
Cardiovascular Disease in Duchenne Muscular Dystrophy
· Taylor Schultz · 2022 · 66 citations · Cited by this paper
Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice
· Haobo Weng · 2024 · 57 citations · Cited by this paper
Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy
· Sun Kyung Kim · 2017 · 51 citations · Cited by this paper
Murine models of Duchenne muscular dystrophy: is there a best model?
· Kristy Swiderski · 2021 · 49 citations · Cited by this paper
Therapeutic Exon Skipping Through a CRISPR-Guided Cytidine Deaminase Rescues Dystrophic Cardiomyopathy in Vivo
· Jia Li · 2021 · 49 citations · Cited by this paper
Engineering M2 macrophage-derived exosomes modulate activated T cell cuproptosis to promote immune tolerance in rheumatoid arthritis
· Guoquan Wu · 2024 · 42 citations · Cited by this paper
CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene
· Tatiana V. Egorova · 2019 · 40 citations · Cited by this paper
Exosome-mediated improvement in membrane integrity and muscle function in dystrophic mice
· Ling Li Leng · 2020 · 37 citations · Cited by this paper
Source: OpenAlex (CC0)